A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2004
Cargando información sobre las referencias
The purpose of this study is to examine the safety and efficacy of CNTO 1275 in participants with active Crohn\'s Disease.
Epistemonikos ID: ee613ab2ffed578d3e881af9cc788eccc594d9e1
First added on: Jul 30, 2018